These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33133244)

  • 41. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.
    Kısaarslan AP; Sözeri B; Gündüz Z; Zararsız G; Poyrazoğlu H; Düşünsel R
    Eur J Rheumatol; 2019 Jul; 6(3):130-135. PubMed ID: 31070580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent hospitalisation with pneumonia is associated with higher 1-year mortality in frail older people.
    Ma HM; Yu RH; Woo J
    Intern Med J; 2013 Nov; 43(11):1210-5. PubMed ID: 23941077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
    Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tobacco smoking increases the risk for death from pneumococcal pneumonia.
    Bello S; Menéndez R; Antoni T; Reyes S; Zalacain R; Capelastegui A; Aspa J; Borderías L; Martin-Villasclaras JJ; Alfageme I; Rodríguez de Castro F; Rello J; Luis M; Ruiz-Manzano J
    Chest; 2014 Oct; 146(4):1029-1037. PubMed ID: 24811098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia.
    Chen L; Miao C; Chen Y; Han X; Lin Z; Ye H; Wang C; Zhang H; Li J; Tang Q; Dong Y; Bai M; Zhu Y; Liu G
    Ital J Pediatr; 2021 Apr; 47(1):100. PubMed ID: 33892752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Community-Acquired Pneumonia in Patients With Diabetes Mellitus: Predictors of Complications and Length of Hospital Stay.
    Bader MS; Yi Y; Abouchehade K; Haroon B; Bishop LD; Hawboldt J
    Am J Med Sci; 2016 Jul; 352(1):30-5. PubMed ID: 27432032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Community-acquired pneumonia during long-term follow-up of patients after radical esophagectomy for esophageal cancer: analysis of incidence and associated risk factors.
    Hanyu T; Kanda T; Yajima K; Tanabe Y; Komukai S; Kosugi S; Suzuki T; Hatakeyama K
    World J Surg; 2011 Nov; 35(11):2454-62. PubMed ID: 21882023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.
    Johnstone J; Eurich DT; Majumdar SR; Jin Y; Marrie TJ
    Medicine (Baltimore); 2008 Nov; 87(6):329-334. PubMed ID: 19011504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
    Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
    Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of comorbid conditions on long-term mortality after pneumonia in older people.
    Yende S; Angus DC; Ali IS; Somes G; Newman AB; Bauer D; Garcia M; Harris TB; Kritchevsky SB
    J Am Geriatr Soc; 2007 Apr; 55(4):518-25. PubMed ID: 17397429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
    Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fatal severe community-acquired pneumonia: risk factors, clinical characteristics and medical errors of hospital patients].
    Postnikova LB; Klimkin PF; Boldina MV; Gudim AL; Kubysheva NI
    Ter Arkh; 2020 Apr; 92(3):42-49. PubMed ID: 32598792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
    Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
    J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PROGRESS - prospective observational study on hospitalized community acquired pneumonia.
    Ahnert P; Creutz P; Scholz M; Schütte H; Engel C; Hossain H; Chakraborty T; Bauer M; Kiehntopf M; Völker U; Hammerschmidt S; Loeffler M; Suttorp N;
    BMC Pulm Med; 2016 Jul; 16(1):108. PubMed ID: 27535544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.
    Duarte FG; Barberino MG; da Silva Moreira S; Reis JN; Spinardi JR; de Almeida RS; Allen KE; Alexander-Parrish R; Brim R; de Araújo Neto CA; Moreira ED
    BMJ Open; 2022 Apr; 12(4):e059824. PubMed ID: 35428648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.
    Tin Tin Htar M; Stuurman AL; Ferreira G; Alicino C; Bollaerts K; Paganino C; Reinert RR; Schmitt HJ; Trucchi C; Vestraeten T; Ansaldi F
    PLoS One; 2017; 12(5):e0177985. PubMed ID: 28542347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
    Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.